FDA-cleared profile

AI-Rad Companion (Cardiovascular)

Siemens Medical Solutions U.S.A. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Adjunctive cardiovascular review for radiologists and physicians in emergency medicine, specialty care, urgent care and general practice, including heart volume, coronary calcium volume, aortic segmentation, aortic diameter measurement and threshold-based highlighting of enlarged diameters.

Clinical role
Adjunctive quantitative and qualitative clinical decision support for qualified clinicians; outputs support interpretation and assessment and do not replace professional review.
Images and patients
CT/CTA · Heart/Cardiovascular
Key limitation
Keep in mind: Only adult DICOM input is labeled in the exact submission. The validated CT reconstruction, scanner, slice and image-quality conditions limit direct generalization; the submission states that no clinical tests were conducted for the introduced modifications, with verification and validation used instead. Outputs require qualified-clinician review.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Adjunctive cardiovascular review for radiologists and physicians in emergency medicine, specialty care, urgent care and general practice, including heart volume, coronary calcium volume, aortic segmentation, aortic diameter measurement and threshold-based highlighting of enlarged diameters.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Heart/Cardiovascular Input: Previously acquired DICOM CT images from adult patients. FDA validation covered non-cardiac chest CT with filtered-backprojection reconstruction from Siemens, GE, Philips and Toshiba/Canon systems; calcium detection also included Siemens iterative reconstruction.
  • Who uses it?Intended users: Radiologists and qualified physicians in emergency medicine, specialty care, urgent care and general practice.
  • What does the software produce?Output: Heart segmentation and volume, total coronary calcium volume, aorta segmentation, aortic diameters at predefined and maximum-diameter locations, threshold-based diameter categories/highlighting, quantitative and textual reports, DICOM Secondary Capture and DICOM Structured Report TID 1500 outputs.
  • What is its most important limitation?Key limitation: Only adult DICOM input is labeled in the exact submission. The validated CT reconstruction, scanner, slice and image-quality conditions limit direct generalization; the submission states that no clinical tests were conducted for the introduced modifications, with verification and validation used instead. Outputs require qualified-clinician review.

Clinical takeaway. Clinical role: Adjunctive cardiovascular review for radiologists and physicians in emergency medicine, specialty care, urgent care and general practice, including heart volume, coronary calcium volume, aortic segmentation, aortic diameter measurement and threshold-based highlighting of enlarged diameters.

Evidence takeaway. Evidence from the reviewed source record: FDA validation reported subject aorta-segmentation Dice 0.924 ± 0.046 in 315 retrospective cases. In 193 cases, including 50% with dilated aorta and 9% with aortic aneurysm, subject aortic diameter bias at nine landmarks was within ±1.5 mm and MAE was at most 2.2 mm; maximum ascending/descending aorta measurements had 95% limits of agreement ±3.51 mm with 91.9% within those limits.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Adjunctive cardiovascular review for radiologists and physicians in emergency medicine, specialty care, urgent care and general practice, including heart volume, coronary calcium volume, aortic segmentation, aortic diameter measurement and threshold-based highlighting of enlarged diameters.
  • Exact product version
  • Checked 2026-09-07
Workflow role
Adjunctive quantitative and qualitative clinical decision support for qualified clinicians; outputs support interpretation and assessment and do not replace professional review.
  • Exact product version
  • Checked 2026-09-07
Required input
Previously acquired DICOM CT images from adult patients. FDA validation covered non-cardiac chest CT with filtered-backprojection reconstruction from Siemens, GE, Philips and Toshiba/Canon systems; calcium detection also included Siemens iterative reconstruction.
  • Exact product version
  • Checked 2026-09-07
Output and clinician action
Heart segmentation and volume, total coronary calcium volume, aorta segmentation, aortic diameters at predefined and maximum-diameter locations, threshold-based diameter categories/highlighting, quantitative and textual reports, DICOM Secondary Capture and DICOM Structured Report TID 1500 outputs.
  • Exact product version
  • Checked 2026-09-07
Care setting
Clinical radiology and physician-care settings using previously acquired adult CT examinations, including emergency, urgent, specialty and general practice workflows.
  • Exact product version
  • Checked 2026-09-07
Intended users
Radiologists and qualified physicians in emergency medicine, specialty care, urgent care and general practice.
  • Exact product version
  • Checked 2026-09-07
Limitations
Only adult DICOM input is labeled in the exact submission. The validated CT reconstruction, scanner, slice and image-quality conditions limit direct generalization; the submission states that no clinical tests were conducted for the introduced modifications, with verification and validation used instead. Outputs require qualified-clinician review.
  • Exact product version
  • Checked 2026-09-07
Evidence summary
FDA validation reported subject aorta-segmentation Dice 0.924 ± 0.046 in 315 retrospective cases. In 193 cases, including 50% with dilated aorta and 9% with aortic aneurysm, subject aortic diameter bias at nine landmarks was within ±1.5 mm and MAE was at most 2.2 mm; maximum ascending/descending aorta measurements had 95% limits of agreement ±3.51 mm with 91.9% within those limits.
  • Exact product version
  • Checked 2026-09-07

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA validation reported subject aorta-segmentation Dice 0.924 ± 0.046 in 315 retrospective cases. In 193 cases, including 50% with dilated aorta and 9% with aortic aneurysm, subject aortic diameter bias at nine landmarks was within ±1.5 mm and MAE was at most 2.2 mm; maximum ascending/descending aorta measurements had 95% limits of agreement ±3.51 mm with 91.9% within those limits.
  • FDA source
  • Exact product version
  • Checked 2026-09-07
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact product version
  • Checked 2026-09-07

The exact FDA endpoints are segmentation and measurement agreement, not disease-detection sensitivity.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact product version
  • Checked 2026-09-07

The exact FDA endpoints are segmentation and measurement agreement, not disease-detection specificity.

Aorta segmentation Dice

0.924 Dice coefficient

  • EndpointAorta segmentation overlap
  • PopulationRepresentative retrospective clinical cohort
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Nine-landmark aortic diameter bias absolute bound

1.5 mm absolute bound

  • EndpointBias of aortic diameter measurements at nine predefined landmarks
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Nine-landmark aortic diameter MAE upper bound

2.2 mm upper bound

  • EndpointMean absolute error of aortic diameter measurements at nine predefined landmarks
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Maximum ascending/descending aorta LoA absolute bound

3.51 mm absolute bound

  • Endpoint95% limits of agreement for maximum ascending and descending aortic diameter measurements
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Maximum ascending/descending aorta measurements within LoA

0.919 proportion

  • EndpointMeasurements within the FDA-reported 95% limits of agreement
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Maximum ascending/descending aorta bias absolute bound

1.5 mm absolute bound

  • EndpointBias of maximum ascending and descending aortic diameter measurements
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

Maximum ascending/descending aorta MAE upper bound

1.8 mm upper bound

  • EndpointMean absolute error of maximum ascending and descending aortic diameter measurements
  • PopulationRepresentative retrospective clinical cohort including 50% dilated-aorta and 9% aortic-aneurysm cases
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360

AI-Rad Companion (Cardiovascular) aorta segmentation validation

  • DesignRepresentative retrospective clinical cohort validation of the updated aorta-segmentation algorithm against the predicate device.
  • Population315 adult CT cases with subgroup evaluation across manufacturers, slice thickness, sex, age and comorbidities.
  • Scopeexact product version
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360
  • Samplen=315
  • IndependenceSponsor or vendor study

K222360

The FDA summary reports average Dice 0.924 ± 0.046 for the subject and 0.910 ± 0.066 for the predicate.

AI-Rad Companion (Cardiovascular) aortic diameter validation

  • DesignRepresentative retrospective clinical cohort with Bland-Altman analysis of nine predefined landmarks and maximum ascending/descending aorta measurements.
  • Population193 adult CT cases, including 50% with dilated aorta and 9% with aortic aneurysm.
  • Scopeexact product version
  • Tested versionAI-Rad Companion (Cardiovascular) VA20 submitted in K222360
  • Samplen=193
  • IndependenceSponsor or vendor study

K222360

The submission states that no clinical tests were conducted for the introduced modifications; the reported evidence is clinical-data-based software validation and verification/validation.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact product version
  • Checked 2026-09-07

The exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Previously acquired DICOM CT images from adult patients. FDA validation covered non-cardiac chest CT with filtered-backprojection reconstruction from Siemens, GE, Philips and Toshiba/Canon systems; calcium detection also included Siemens iterative reconstruction.

    Scope: Exact product version.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-07 · FDA 510(k) K222360: AI-Rad Companion Cardiovascular

  2. Routing

    Source context, not route validation: The exact submission describes DICOM CT input and forwarding of quantitative, structured and textual reports plus DICOM Secondary Capture to PACS; VA20 adds a human- and machine-readable DICOM Structured Report using TID 1500.

    Scope: Exact product version.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · FDA 510(k) K222360: AI-Rad Companion Cardiovascular

  3. AI processing

    Source context, not route validation: The VA20 submission describes both cloud and edge on-premise deployments; the edge configuration processes data and results in the customer environment while remaining connected to the cloud for monitoring and maintenance.

    Scope: Exact product version.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-07 · FDA 510(k) K222360: AI-Rad Companion Cardiovascular

  4. Returned objects

    Source context, not route validation: Heart segmentation and volume, total coronary calcium volume, aorta segmentation, aortic diameters at predefined and maximum-diameter locations, threshold-based diameter categories/highlighting, quantitative and textual reports, DICOM Secondary Capture and DICOM Structured Report TID 1500 outputs.

    Scope: Exact product version.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-07 · FDA 510(k) K222360: AI-Rad Companion Cardiovascular

  5. Viewer/worklist/report

    Unresolved route: Heart segmentation and volume, total coronary calcium volume, aorta segmentation, aortic diameters at predefined and maximum-diameter locations, threshold-based diameter categories/highlighting, quantitative and textual reports, DICOM Secondary Capture and DICOM Structured Report TID 1500 outputs.

    Scope: Exact product version.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-07 · FDA 510(k) K222360: AI-Rad Companion Cardiovascular

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The VA20 submission describes both cloud and edge on-premise deployments; the edge configuration processes data and results in the customer environment while remaining connected to the cloud for monitoring and maintenance.
  • Exact product version
  • Checked 2026-09-07
Integration
The exact submission describes DICOM CT input and forwarding of quantitative, structured and textual reports plus DICOM Secondary Capture to PACS; VA20 adds a human- and machine-readable DICOM Structured Report using TID 1500.
  • Exact product version
  • Checked 2026-09-07
Security
Siemens Healthineers' corporate cybersecurity page states a Secure Development Lifecycle addressing pre-market and post-market phases for products under development and a range of existing offerings; a Cybersecurity Management Service maintaining a product security inventory (over 1,000 product versions and over 21,000 monitored software components) with security whitepapers, SBOMs and vulnerability assessments available to customers via teamplay Fleet; incident and vulnerability management channels; and that Siemens Healthineers AG maintains an independent certification of its global Cybersecurity Management System to ISO/IEC 27001:2022 extended by ISO/IEC 27701:2019, with the certificate referenced to the SGS directory. Vendor statement; no certificate or report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.

Monitoring
Siemens Healthineers' cybersecurity page states that its Cybersecurity Management Service maintains a product security inventory of over 1,000 product versions and over 21,000 monitored software components, with security whitepapers, SBOMs and vulnerability assessments delivered via teamplay Fleet, and that it operates incident and vulnerability management.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.

Cloud and edge/on-premise deployment

The VA20 submission describes cloud and edge on-premise deployments, with edge processing in the customer environment while remaining connected to the cloud for monitoring and maintenance.

exact product version · checked 2026-09-07

Structured and PACS-ready reporting

VA20 generates quantitative, structured and textual reports, DICOM Secondary Capture and a human- and machine-readable DICOM Structured Report using TID 1500 for transfer to clinical systems.

exact product version · checked 2026-09-07

Family PACS/web review workflow

Siemens' current family whitepaper describes reconstructed thorax CT being sent to PACS and in parallel to AI-Rad Companion, with results delivered to web-based review or directly to PACS and used with original data for reporting.

product family · checked 2026-09-07

The reviewed whitepaper covers current VA40A/VA22A family material; it does not establish that every feature or connector is present in K222360 VA20.

Review, accept/decline and send-to-PACS interaction

The Siemens cardiovascular job aid shows calcium and heart-volume findings, nine aortic landmarks with diameters and threshold-based color coding; users can accept or decline findings before sending the case to PACS.

product family · checked 2026-09-07

This is 2019 training material, explicitly not an operator manual and not necessarily current; optional functions and country availability require confirmation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K222360
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact product version
  • Checked 2026-09-07
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact product version
  • Checked 2026-09-07
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-04-06
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
20Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored candidate metadata was screened. The broad AI-Rad Companion query returned 20 PubMed and one trial identifier without exact K222360 VA20 linkage established in metadata; no full paper or trial record was reviewed, and no candidate is promoted as product evidence. The current discovery snapshot contains 20 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor technical documentation, vendor training material, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-07 - Exact product version

    No public price or quote for the exact VA20 configuration was reviewed.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Siemens Healthineers AI-Rad Companion reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

9 sources - 3 history items

Source ledger

  1. FDA 510(k) K222360: AI-Rad Companion Cardiovascular

    U.S. Food and Drug Administration - Published 2023-04-06 - Accessed 2026-09-07

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. AI-Rad Companion Chest CT model card (K222360)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: purpose, modality, intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. AI-Rad Companion Cardio VA23 instructions for use

    Siemens Healthineers - Accessed 2026-09-08

    Scope: productFamily, deployment, DICOM, implementationCapabilities

  8. Siemens Healthineers AI-Rad Companion Academy

    Siemens Healthineers - Accessed 2026-09-08

    Scope: productFamily, training, implementationCapabilities

  9. Siemens Healthineers: Cybersecurity

    Siemens Healthineers - Accessed 2026-10-26

    Scope: security

Research history

  1. K222360 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252217

CT VScore+

Canon Medical Informatics, Inc.

Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-11-28
FDA-cleared K251027

cvi42 Coronary Plaque Software Application

Circle Cardiovascular Imaging, Inc.

Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-10-27
FDA-cleared K251656

Careverse CoronaryDoc (Careverse CoronaryDoc)

Careverse Technology Pte. Ltd.

Authorized purpose: Careverse CoronaryDoc is a web-based tool for trained medical professionals to view and analyze CCTA CT data for coronary plaques and stenosis, with coronary measurements, visualization, automated plaque and stenosis outputs, and structured reporting for physician review.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-09-04

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history